Progestogen therapy and prevention of functional ovarian cysts during pituitary desensitisation with GnRH agonists.
Aston
K
K
Department of Obstetrics and Gynaecology, University of Southampton, Princess Anne Hospital, UK.
Arthur
I
I
Masson
G M
GM
Jenkins
J M
JM
D000281:Administration, Intranasal; D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D002064:Buserelin / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D005498:Follicular Phase / Q000187:drug effects; D006801:Humans; D010048:Ovarian Cysts / Q000517:prevention & control*; D010902:Pituitary Gland / Q000187:drug effects; D011372:Progestins / Q000627:therapeutic use*; D011446:Prospective Studies
D018931:Antineoplastic Agents, Hormonal; D011372:Progestins; D002064:Buserelin